GF
INZY

Gabelli Funds’s Inozyme Pharma INZY Stock Holding History

Gabelli Funds’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,457,800
Closed -$5.83M – 1273
2025
Q2 		$5.83M Buy
+1,457,800
New +$3.61M 0.04% 449

Gabelli Funds's INZY Position: Q3 2025 in Review

Gabelli Funds sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 1,457,800 shares — an estimated $5.83M sold.

Gabelli Funds first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $5.83M in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

  • Gabelli Funds reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
  • Gabelli Funds sold 1,457,800 Inozyme Pharma shares in Q3 2025, an estimated $5.83M.
  • Gabelli Funds first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
  • Gabelli Funds's Inozyme Pharma position peaked at $5.83M in Q2 2025.
  • 0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Gabelli Funds's 13F filing for Q3 2025, filed 12 Nov 2025.